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Abstract
Shared decision-making (SDM) between clinicians and patients is a key component of patient experience, but measurement
efforts have been hampered by a lack of valid and reliable measures that are feasible for routine use. In this study, we aim to
investigate collaboRATE’s reliability, calculate required sample sizes for reliable measurement, and compare Consumer
Assessment of Healthcare Providers and Systems (CAHPS) patient experience survey items to collaboRATE. Colla-
boRATE’s provider group-level reliability reached acceptable reliability at 190 patient reports, while the CAHPS SDM
measure demonstrated similar reliability at a sample size of 124. The CAHPS communication measure reached acceptable
reliability with 55 patient reports. A strong correlation was observed between collaboRATE and CAHPS communication
measures (r ¼ 0.83). As a reliable measure of SDM, collaboRATE may be useful for both building payment models that
support shared clinical decision-making and encouraging data transparency with regard to provider group performance.
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Background
Given increasing reliance on patient experience measures in
US performance-based compensation systems, as well as
evolving public expectations with regard to patient-
centered health care, a focus on patient experience is critical
(1). Patient experience measurement has been described as
“reports from patients on what they did or did not experience
in their interactions with providers and the healthcare sys-
tem” (2). In addition to the importance of positive patient
experience per se, there is increasing evidence of positive
correlations between experience, patient safety, and clinical
outcomes (3). Improving the measurement and transparency
of patients’ experience could contribute widely to improve-
ment in the quality of healthcare delivery.
As a key component of patient experience, shared
decision-making (SDM) between clinicians and patients has
garnered increased attention in recent years, having been
promoted in the US Patient Protection and Affordable
Care Act (4,5) and championed as “the pinnacle of
patient-centered care” (6). However, the ability to assess
patients’ experience of SDM has been hampered by a lack
of measures that have proven psychometric properties
such as validity, responsiveness, and, critical for provider
group performance assessment, reliability, while at the
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same time are practical enough for use in routine clinical
settings. This measurement gap also hinders SDM perfor-
mance improvement.
To help meet this need, Elwyn and colleagues developed
collaboRATE, a 3-item patient-reported measure of SDM
process that applies to any healthcare decision, has strong
face validity among its target population, and is possible to
complete in less than 30 seconds (7). Preliminary psycho-
metric testing of collaboRATE in a simulated, online sample
has established its concurrent validity with existing research-
oriented patient-reported measures of SDM such as the
SDM-Q-9 questionnaire (8,9). A feasibility study in 3 US
primary care practices has demonstrated its practicable use
in routine ambulatory healthcare service (10).
Another approach to SDM measurement was undertaken
by the US Agency for Healthcare Research and Quality as a
supplement to the widespread Consumer Assessment of
Healthcare Providers and Systems (CAHPS) Clinician and
Group Survey (CG-CAHPS version 3.0). The CAHPS sur-
vey is used by providers and payers of US health-care ser-
vices to “evaluate and compare healthcare providers and to
improve the quality of healthcare services” (11). The
CAHPS supplemental SDM section focuses on
medication-related decisions—discussing reasons to take
medication, discussing reasons not to take medication, and
discussing which medication is best. The CAHPS commu-
nication items evaluate clinician performance in explaining
things in a way that is easy to understand, listening care-
fully, showing respect, and spending enough time with the
patient.
Although CAHPS scores have been evaluated in various
healthcare settings, no prior studies have compared CAHPS
communication and SDM measures to collaboRATE on key
elements of provider group performance measurement. In the
current study, we therefore aim to (1) report on provider group
performance on collaboRATE administered in a CAHPS-like
survey, (2) compare required sample sizes for reliable provi-
der group performance profiling using collaboRATE to those
required for CAHPS patient experience survey items relating
to clinician communication and SDM, and (3) evaluate colla-
boRATE’s concurrent validity with CAHPS clinician com-
munication and SDM composite scores.
Methods
Data Sources
We conducted a secondary analysis of the full cross-
sectional 2017 California Patient Assessment Survey data
set. The Patient Assessment Survey is administered annually
by the Pacific Business Group on Health to adult patients of
153 California provider groups taking commercial capitation
risk, and results are incorporated into California’s pay-for-
performance program. Participating provider groups are geo-
graphically diverse practices representing all of California’s
major metropolitan regions as well as rural areas within the
state. Each provider group includes both primary and speci-
alty care clinicians.
Our use of the deidentified 2017 Patient Assessment Sur-
vey data set was approved by the Pacific Business Group on
Health. This project was considered exempt from further
review by Dartmouth College’s Committee for the Protec-
tion of Human Subjects (study #31002).
Participants. Patient Assessment Survey participants include
privately insured adult (aged 18 years and older) patients
who received ambulatory healthcare services at one of the
153 participating California provider groups between
January and October 2016. The Patient Assessment Survey’s
standard sampling procedure excludes patients younger
than 18 years of age, uninsured patients, and patients with
public or other noncommercial health insurance. Therefore,
our secondary analysis of the Patient Assessment Survey
data set also excludes these populations.
Questionnaire administration. In accordance with the standard
Patient Assessment Survey administration procedure, a ran-
dom sample of eligible patients were invited to complete the
survey. The recruitment protocol included a series of survey
administration modes, beginning with e-mail invitations and
progressing to mail then attempting telephone administration
for prior nonrespondents. All questionnaires were adminis-
tered between December 2016 and March 2017. Question-
naires were available in English, Spanish, Chinese, Korean,
and Vietnamese languages.
Measures. The 2017 Patient Assessment Survey consisted of
35 total items derived from (1) the CAHPS Clinician & Group
version 3.0 survey and supplement (12) and (2) the collabo-
RATE measure (7). This study focused on 10 items related to
clinician communication and SDM, listed in Table 1.
Consumer Assessment of Healthcare Providers and
Systems SDM item responses were given on a yes/no
response scale, while CAHPS communication items were
rated on a never/sometimes/usually/always response
scale. CollaboRATE items were rated on an ordinal scale
from 0, labeled “Worst care possible,” to 10, labeled
“Best care possible.”
Statistical Analysis
In all analyses, survey responses with missing data on the
outcome measure of interest were excluded from the analy-
sis. Due to our interest in evaluating reliability under a
worst-case scenario that emphasizes the relation of missing
data to reliability, we did not use multiple imputation. Data
were unweighted and physician group scores were case-mix
adjusted by patient age, education, general and mental health
status, race/ethnicity, mode and language of survey admin-
istration, and provider specialty. Analysis was conducted
using Stata 13 statistical software.
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Scoring methods. For each of the 3 measures (collaboRATE,
CAHPS communication, and CAHPS SDM), item scores
were calculated by provider group as the proportion of all
responses in which a top score (ie, “10” for collaboRATE
items, “Always” for CAHPS communication items, and
“Yes” for CAHPS SDM items) was given. Overall top-box
scores represent the proportion of responses in which top
scores were given on all items in the measure. Composite
scores were calculated as the mean of the measure’s item
scores. We scored each measure according to its customary
approach: previously validated top-box scoring was adopted
for collaboRATE (9), while CAHPS mean scoring was used
for CAHPS communication and SDM composites. Ceiling
effects, where responses tend toward the upper extreme of a
measurement scale, are common among patient-reported
experience measures such as collaboRATE. To mitigate
these ceiling effects, and in accordance with the standard
scoring procedures for each included measure, we followed
the precedent specified by Barr et al (9) and adopted top-box
scoring in which the highest possible score of 10 constituted
the top box.
Provider group-level reliability analysis. Score reliability is a sta-
tistical measure of “how well one can confidently distinguish
the performance of one physician [or provider group] from
another” (13). The reliability of provider group performance
scores depends on 2 things: “(1) a sufficient number of
patients eligible for a given quality measure ([eg, SDM] per
provider group) and (2) performance variation across [pro-
vider groups] on that quality measure (14).” To evaluate
provider group-level score reliability, we adopted the
approach used by Scholle and detailed by Adams (13,14).
For each measure (CAHPS communication, CAHPS SDM,
and collaboRATE), we estimated a mixed effects logistic
regression model and the intracluster correlation coefficient
(ICC) implied by the model. We then calculated provider
group-level score reliability using the procedure specified by
Adams (13) and the formula detailed by Snijders and Bosker
(15), reproduced in Table 2, where r is the case-mix adjusted
ICC and n is the provider group-level sample size. This




2 denotes the between provider
group variance and s2 is the within provider group (between
patient) variance, showing that reliability equals ICC when
n ¼ 1 and otherwise exceeds the ICC.
We report ICCs and median reliability estimates for each
measure and across all provider groups (14). As reliability
depends heavily on sample sizes, we also report response
rates for each measure. Finally, we conducted a sensitivity
analysis to determine the impact of the patient case-mix
adjustment on provider group-level score reliability.
A minimum threshold for acceptable score reliability for
performance profiling at the provider group level has been
established at 0.70 (13,14). We therefore present the mini-
mum number of patient reports required at the provider
group level to reach the minimum 0.70 reliability threshold
for each included measure.
Concurrent validity analysis. To examine concurrent validity
between CAHPS communication, CAHPS SDM, and colla-
boRATE measures, we conducted Pearson correlation anal-
ysis comparing provider group-level scores by individual
item as well as by composite and top-box score.
Limitations
Our study design had several limitations. First, as per Patient
Assessment Survey standard procedures, questionnaires
were administered to patients more than 2 months following
their clinic visits, presenting the possibility of recall bias.
Further, the 10 survey items analyzed in this study were
among 28 total items contained within the 2017 Patient
Assessment Survey; the impact of those additional 18 items
on possible selection and response biases is unknown.
Finally, we have access to demographic data only for respon-
dents to the Patient Assessment Survey; we do not have
access to detailed data on their respective healthcare
Table 1. Shared Decision-Making and Communication Survey
Items.
collaboRATE Items CAHPS SDM Items
CAHPS Communi-
cation Items





Did you and this
doctor talk about
the reasons you
might want to take
medicine?
How often did this
doctor explain
things in a way that
was easy to
understand?
How much effort did
this doctor make
to listen to the
things that matter
most to you about
your health issues?
Did you and this
doctor talk about
the reasons you
might not want to
take medicine?
How often did this
doctor listen
carefully to you?





what to do next?









How often did this
doctor show
respect for what
you had to say?




Abbreviations: CAHPS, Consumer Assessment of Healthcare Providers and
Systems; SDM, shared decision-making.
Table 2. Snijders and Bosker (1999) Reliability Formula.
reliability ¼ nr1þðn1Þr
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providers or provider groups. We are therefore unable to
further contextualize our results based on these individual
provider and group characteristics.
Results
A demographic profile of patient respondents from 153 par-
ticipating provider groups is available in Online Appendix 1.
CollaboRATE and CAHPS scores
The 2017 Patient Assessment Survey included 31 265
patient responses across 153 California provider groups.
CollaboRATE scores varied by provider group, with top-
box scores ranging from 36.7% to 74.8%. The overall mean
collaboRATE score was 59.4%. Figure 1 displays the distri-
bution of collaboRATE scores by provider group. The
CAHPS communication composite scores ranged from
60.4% to 91.8% across provider groups, and CAHPS SDM
composite scores ranged from 74.2% to 94.6%. Group-level
scores for each CAHPS communication and SDM composite
and individual item are listed in Table 3.
Provider Group-Level Score Reliability
Based on case-mix adjusted scores, collaboRATE provider
group-level reliabilities had a median value of 0.71 (at n ¼
204; reliability range: 0.28-0.93 with n ranging 31-1133), while
the median CAHPS SDM group-level reliability (at n ¼ 105)
was 0.67 (range: 0.23-0.92 with n ranging 16-614). Group-
level reliability of CAHPS communication items had a median
value of 0.90 (range: 0.57-0.98 with n ranging 31-1127). Relia-
bility results are summarized in Table 4.
Given its ICC of 0.01, collaboRATE reaches 0.70 relia-
bility with 190 patient reports. The CAHPS communication
composite, with an ICC of 0.04, reaches 0.70 reliability with
55 patient reports and the CAHPS SDM composite, with an
ICC of 0.02, reaches 0.70 reliability with 124 patient reports.
CollaboRATE had a 100% response rate among the 31
265 total patient respondents, while the CAHPS communi-
cation composite was answered by 99.6% of respondents (n
¼ 31 129) and the CAHPS SDM composite was answered by
52.6% of respondents (n ¼ 16 460).
In sensitivity analysis of scores unadjusted for patient
case mix, the CAHPS communication and SDM group-
level composite scores shifted an average of 11.5% and
16.1%, respectively, following case-mix adjustment;
collaboRATE scores remained consistent with, on average,
only a 0.2% change in group-level scores. CAHPS commu-
nication group-level scores had a range of 65.2% to 91.4%
(mean ¼ 82.7%) after case-mix adjustment, compared with
a range of 44.1% to 85.4% (mean ¼ 83.2%) preadjustment.
Similarly, CAHPS SDM scores ranged 74.2% to 94.7%
(mean ¼ 86.4%) after case-mix adjustment and 50% to
87.7% (mean ¼ 87.0%) preadjustment. CollaboRATE
scores ranged 36.7% to 74.8% (mean ¼ 59.4%) after
case-mix adjustment and 36.5% to 75.0% (mean ¼
60.0%) preadjustment, suggesting little change in the inter-
group variance after case-mix adjustment of collaboRATE
scores.
Concurrent Validity
At the measure level, the strongest association was observed
between collaboRATE and the CAHPS communication
composite (r ¼ 0.83). Correlations were moderate between
the CAHPS SDM composite and collaboRATE (r ¼ 0.52)
and the CAHPS SDM and communication composites (r ¼
0.61). Figure 2 shows correlations between collaboRATE
and CAHPS at both composite and item levels.
Between individual items, strong associations were
observed among the collaboRATE items themselves; this
correlation was especially pronounced between the collabo-
RATE “listen” and “help you understand” items (r ¼ 0.94).
The collaboRATE “listen” item was also highly correlated
with the CAHPS “spend time” (r¼ 0.83), “listen” (r¼ 0.82),
and “respect” (r ¼ 0.81) items. The 3 CAHPS SDM items
had low-to-moderate correlations with the 3 collaboRATE
items (range: r ¼ 0.22-0.53).
Figure 1. Case-mix adjusted collaboRATE top-box scores by pro-
vider group (n ¼ 153 groups).











CAHPS “start medication” 88.0%-99.2%
CAHPS “stop medication” 60.5%-91.7%
CAHPS “best medication” 69.3%-93.7%
Abbreviations: CAHPS, Consumer Assessment of Healthcare Providers and
Systems; SDM, shared decision-making.
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Discussion
Key Findings
Although collaboRATE shows a range of scores across the
153 provider groups represented in this sample, ICCs for all
3 included measures were low, meaning that relatively large
sample sizes are needed to reach adequate levels of reliabil-
ity for performance profiling applications. CollaboRATE
demonstrates adequate reliability for performance profiling
(13) with a minimum of 190 patient responses per provider
group, the CAHPS communication composite reaches ade-
quate reliability with a minimum of 55 patient responses per
provider group, and the CAHPS SDM composite reaches
adequate reliability with a minimum of 124 patient responses
per provider group.
Correlation analysis demonstrates limited association
between the collaboRATE measure and the CAHPS SDM
composite, indicating a lack of concurrent validity between
these 2 measures of SDM. Correlations are substantially
higher between collaboRATE and CAHPS communication
measures. Item-level analysis showed that CAHPS commu-
nication items are highly associated with collaboRATE
items—an intuitive relationship between a measure of
SDM and a measure of closely related communication
practices including explaining, listening, showing respect,
and spending enough time. It is possible that a provider’s
engagement in SDM may, in fact, result in higher commu-
nication ratings. Despite this high correlation between
CAHPS communication and collaboRATE measures, there
is insufficient evidence to conclude that the CAHPS
Table 4. Provider Group-Level Reliability.
Measure Median Sample Size (n) ICC (r) Median Reliability Reliability Range (n ¼ 153 Provider Groups)
Adjusted scores
collaboRATE 204 0.01 0.71 0.28-0.93
CAHPS SDM 105 0.02 0.67 0.23-0.92
CAHPS communication 204 0.04 0.90 0.57-0.98
Unadjusted scores
collaboRATE 204 0.01 0.74 0.30-0.94
CAHPS SDM 105 0.03 0.79 0.36-0.96
CAHPS communication 204 0.05 0.91 0.61-0.98
Abbreviations: CAHPS, Consumer Assessment of Healthcare Providers and Systems; ICC, intracluster correlation coefficient; SDM, shared decision-making.
Figure 2. CollaboRATE correlations with Consumer Assessment of Healthcare Providers and Systems (CAHPS) communication and
shared decision-making measures.
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communication composite adequately captures SDM
performance. Instead, a lack of face validity caused by
exclusion of a key element of SDM, namely including
patients’ preferences in treatment planning or other
next steps, calls into question the validity of the CAHPS
communication composite as a proxy for SDM perfor-
mance (7,16).
As the CAHPS SDM measure specific to medication
decision-making is relevant to only the fraction of clinical
encounters in which patients and providers make explicit
decisions about starting or stopping a medication (no more
than 52.6% of respondents in this sample), sample sizes for
the CAHPS SDM measure are consistently low; these smaller
sample sizes (median n ¼ 105 across 153 provider groups
compared to median n ¼ 204 for collaboRATE and CAHPS
communication measures) hinder the measure’s reliability. In
this case, the ability of the measure to detect true differences
between provider groups is compromised—even when there
is just as much true variation. This issue of limited relevance
to a variety of clinical encounters highlights the need for a
generic and broadly applicable measure of SDM such as col-
laboRATE to be collected on a routine basis. Further, as the
third collaboRATE item (“include”) captures the definitive
element of SDM (7,16,17), the low correlation between the
collaboRATE “include” item and CAHPS SDM composite
score suggests there is a construct mismatch inherent to the
CAHPS SDM measure. Established concurrent validity
between collaboRATE and SDM-Q-9, a validated research
measure of SDM (9), and the lack of concurrent validity
between collaboRATE and the CAHPS SDM composite
demonstrated in this study together indicate that the CAHPS
SDM composite lacks construct validity as a measure of SDM
performance. This lack of construct validity, paired with inad-
equate reliability for performance measurement at the provi-
der group level, suggests that the CAHPS SDM composite is
an inadequate group-level measure of SDM performance.
Context in Existing Literature
While a strict reliability standard of 0.70 ensures fair com-
parison across provider groups for national or regional per-
formance management and incentivization purposes, we
recognize that obtaining the required sample sizes to meet
this reliability standard may be too resource-intensive to be
attainable in local quality improvement and research proj-
ects. For these local projects, we therefore recommend 20 to
30 observations per provider group in analyses designed to
assess differences between groups and approximately 50
observations per provider group for inferential analyses (18).
Our findings support Hays’ evaluation of CAHPS mea-
sure reliability, which found larger required sample sizes for
the CAHPS SDM composite (n ¼ 396) than for the CAHPS
communication composite (n ¼ 295) (19). However, that
study’s use of the Spearman-Brown reliability formula
(20) resulted in larger recommended sample sizes than those
we report in the current study (CAHPS communication:
n¼ 55; CAHPS SDM: n¼ 124) which used Adams’ estima-
tion approach (13).
We observed consistent mean collaboRATE scores both
pre- and post-case-mix adjustment, with a substantial
upward post-adjustment shift in group-level scores occurring
primarily at the low end of the range. This is consistent with
prior research finding that “case-mix adjustment of practice-
level scores results in relatively few large adjustments
(which were mainly positive), and many small adjustments
(which were more often negative)” (21). Patient-level fre-
quencies show that the majority of respondents self-identify
as Asian in the 5 provider groups with the lowest unadjusted
collaboRATE scores. More research is needed to explore the
patient-level predictors of collaboRATE scores.
Adjusting for case mix is often advocated in healthcare
quality measurement (21). It is likely that SDM scores
will vary because of patient characteristics; language bar-
riers, literacy levels, and other patient sociodemographic
factors may limit perceived (or actual) SDM. Case-mix
adjustment parses the variance attributable to provider
performance from the variance associated with patient
characteristics. Hence, as case-mix adjustment reduces
overall variation between measured entities (22), the
reliability measures based on case-mix adjusted scores
may represent lower bound estimates, while the reliability
measures calculated using unadjusted scores can be con-
sidered upper bound estimates.
Conclusion
Valid measurement relies on clarity about the constructs
being measured, as well as meaningful interpretation of var-
iation in scores. In this study, we demonstrate that collabo-
RATE has adequate reliability for provider group
performance profiling with a minimum sample size of 190
patient reports. With this minimum sample size and given its
fidelity to the core dimensions of SDM, collaboRATE could
be considered as a group-level SDM performance measure.
Smaller samples may be useful for quality improvement
initiatives. Further research is needed to evaluate the rela-
tionship between patient case mix and patients’ experience
of SDM, and to investigate collaboRATE’s reliability as a
measure of individual clinician performance.
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